Table 2 from Prostate Health Index (Phi) and Prostate Cancer Antigen 3 (PCA3) Significantly Improve Prostate Cancer Detection at Initial Biopsy in a Total PSA Range of 2–10 ng/ml | Semantic Scholar
Improvement of Prostate Cancer Diagnosis by Detecting PSA Glycosylation-Specific Changes
Prostate Specific Antigen: The Controversial Tumor Marker | AACC.org
Scatter plots of total PSA (A), fPSA (B), ACT-PSA (C), and cPSA (D) in... | Download Scientific Diagram
Prostate-Specific Antigen Testing: Overview, Physiologic Characteristics of PSA, Other Prostate Cancer Markers
Reactivity of free PSA () and PSA-ACT (F) in the Tandem-R free PSA assay. | Download Scientific Diagram
JCM | Free Full-Text | The Association between Prostate-Specific Antigen Velocity (PSAV), Value and Acceleration, and of the Free PSA/Total PSA Index or Ratio, with Prostate Conditions
Diagnostics | Free Full-Text | MRI-Based Radiomics Nomogram for Predicting Prostate Cancer with Gray-Zone Prostate-Specific Antigen Levels to Reduce Unnecessary Biopsies
Cancers | Free Full-Text | The Role and Significance of Bioumoral Markers in Prostate Cancer
PDF] Reference reagents for prostate-specific antigen (PSA): establishment of the first international standards for free PSA and PSA (90:10) | Semantic Scholar
Prostate Health Index (Phi) and Prostate Cancer Antigen 3 (PCA3) Significantly Improve Prostate Cancer Detection at Initial Biopsy in a Total PSA Range of 2–10 ng/ml | PLOS ONE
Prostate-specific antigen - Wikipedia
Markers of Toxicity and Response to Radiation Therapy in Patients With Prostate Cancer - Advances in Radiation Oncology
PDF] Reference reagents for prostate-specific antigen (PSA): establishment of the first international standards for free PSA and PSA (90:10) | Semantic Scholar
PDF] Reference reagents for prostate-specific antigen (PSA): establishment of the first international standards for free PSA and PSA (90:10) | Semantic Scholar
Diagnostic validity of tPSA, cPSA, and the fPSA/ tPSA, cPSA/tPSA, and... | Download Table
The performance of [-2]proPSA and prostate health index tumor markers in prostate cancer diagnosis
Greater PSA Decline Predicts Better 177Lu-PSMA-617 Outcomes in mCRPC - Renal and Urology News
International Braz J Urol ::
Clinical validation of IsoPSA, a single parameter, structure-focused assay for improved detection of prostate cancer: A prospective, multicenter study - ScienceDirect
2-DE Western blot of serum PSA forms from patient with PCa (total PSA:... | Download Scientific Diagram
What is the difference between PSA and free PSA? - Harvard Health
A predictive model for prostate cancer incorporating PSA molecular forms and age | Scientific Reports
Improving the diagnosis of prostate cancer by telomerase-positive circulating tumor cells: A prospective pilot study - eClinicalMedicine
Prostate specific antigen: a useful but limited marker for prostate cancer
Serum PSA-based early detection of prostate cancer in Europe and globally: past, present and future | Nature Reviews Urology
Molecular Form Differences Between Prostate-Specific Antigen (PSA) Standards Create Quantitative Discordances in PSA ELISA Measurements | Scientific Reports
NACB recommendations for the clinical use of PSA serum markers in the... | Download Table